BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22677127)

  • 1. Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.
    Rollin J; Pouplard C; Gratacap MP; Leroux D; May MA; Aupart M; Gouilleux-Gruart V; Payrastre B; Gruel Y
    Blood; 2012 Aug; 120(6):1309-16. PubMed ID: 22677127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.
    Zhou Y; Abraham S; Renna S; Edelstein LC; Dangelmaier CA; Tsygankov AY; Kunapuli SP; Bray PF; McKenzie SE
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2315-2323. PubMed ID: 27765766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
    Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
    Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes.
    Gruel Y; Pouplard C; Lasne D; Magdelaine-Beuzelin C; Charroing C; Watier H
    Blood; 2004 Nov; 104(9):2791-3. PubMed ID: 15191947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
    Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
    J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
    Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
    Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
    J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
    Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
    Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.
    Lhermusier T; van Rottem J; Garcia C; Xuereb JM; Ragab A; Martin V; Gratacap MP; Sié P; Payrastre B
    J Thromb Haemost; 2011 Oct; 9(10):2067-76. PubMed ID: 21848694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
    Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
    Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis.
    Senis YA; Tomlinson MG; Ellison S; Mazharian A; Lim J; Zhao Y; Kornerup KN; Auger JM; Thomas SG; Dhanjal T; Kalia N; Zhu JW; Weiss A; Watson SP
    Blood; 2009 May; 113(20):4942-54. PubMed ID: 19246339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
    Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
    Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases.
    Ellison S; Mori J; Barr AJ; Senis YA
    J Thromb Haemost; 2010 Jul; 8(7):1575-83. PubMed ID: 20345711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
    J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation.
    Gratacap MP; Hérault JP; Viala C; Ragab A; Savi P; Herbert JM; Chap H; Plantavid M; Payrastre B
    Blood; 2000 Nov; 96(10):3439-46. PubMed ID: 11071639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.